Ektare, V., Simons, C., Johannesen, K., Krause, T., Zema, C. L., Buisman, L. R., Treur, M., Moura, A., Dasari, M., Verkaik, M., van de Wetering, G., Pronk, L., Pompen, M., Li, X., Contente, M., Knackstedt, C., & Hurst, M. (2026). A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspective. Journal of Medical Economics, 29(1), 1595-1616. https://doi.org/10.1080/13696998.2026.2675850

Terron, M. C., Rossi, C., Krause, J., Schroen, B., Herum, K. M., & Nieuwenhoven, F. A. V. (2026). Cartilage intermediate layer protein (CILP) in cardiac fibrosis: Protective or pathogenic?Matrix Biology, 147, Article 102032. https://doi.org/10.1016/j.matbio.2026.102032

Allach, Y., de Jong, M. B. . L., Clephas, P. R. D., Abou Kamar, S., Rocca, H. P. B.-L., Handoko, M. L., van Halm, V. P., Kok, W. E. M., Asselbergs, F. W., van Kimmenade, R. R. J., Beeres, S. L. M. A., Rienstra, M., Szymanski, M. K., de Boer, R. A., Kardys, I., & Brugts, J. J. (2026). Pathophysiological analysis of serially measured plasma biomarkers, remote monitoring and clinical events, in symptomatic patients with moderate to severe chronic heart failure. IJC Heart and Vasculature, 65, Article 101970. https://doi.org/10.1016/j.ijcha.2026.101970

Fudim, M., Van Empel, V., Zehnder, T., Sauty, B., Esposito, C., Balazard, F., Mayer, I., Hallal, M., Loiseau, N., Weerts, J., Patel, M., Balu, S., Hintze, B., Torres, F., Micsinai, M., Rigolli, M., Kessler, P., Touzot, M., Lund, L. H., ... Butler, J. (2026). CONFIDENT-HFpEF: a machine learning-based risk stratification for mortality and hospitalization using multimodal real-world data. Esc heart failure, 13(4), Article xvag097. https://doi.org/10.1093/eschf/xvag097

Sunderland, N., Asselin, G., Henry, A., Nelson, C. P., Lemieux Perreault, L. P., Asselbergs, F. W., Boersma, E., Cappola, T. P., Chazara, O., Chutkow, W., Cyr, M. C., Gkatzionis, A., Gui, H., Haefliger, C., Hedman, Å. K., Hillege, H., Hyde, C. L., Kamanu, F. K., Kardys, I., ... Lumbers, R. T. (2026). Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study. Journal of the American College of Cardiology, 87(21), 2981-2992. https://doi.org/10.1016/j.jacc.2026.02.5093

Sikking, M. A., Peisker, F., Maatz, H., Lopez-Anguita, N., Hazebroek, M. R., Henkens, M. T. H. M., Raafs, A. G., Heymans, A. B. M., Stroeks, S. L. V. M., Abdul Hamid, M. A., Li, X., Vicenzetto, C., Caforio, A. L. P., Brunner-La Rocca, H.-P., Knackstedt, C., van Paassen, P., van Empel, V. P. M., Hubner, N., Verdonschot, J. A. J., & Heymans, S. R. B. (2026). Improved outcome up to 10 years after intravenous immunoglobulin therapy in patients with dilated cardiomyopathy. European journal of heart failure. Advance online publication. https://doi.org/10.1093/ejhf/xuag134

Kok, T. F., van Essen, B. J., Weerts, J., Yang, Y., Achten, A., Gansevoort, R. T., Bakker, S. J. L., van Empel, V., Damman, K., Boersma, E., Kardys, I., Voors, A. A., de Boer, R. A., & Suthahar, N. (2026). Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction. Mayo Clinic Proceedings, 101(6), 920-931. https://doi.org/10.1016/j.mayocp.2025.08.022

Peters, C., & Brunner-La Rocca, H.-P. (2026). Natriuretic peptides-a screening tool for heart failure?European heart journal - Quality of care & clinical outcomes, 12(4), 477-478. https://doi.org/10.1093/ehjqcco/qcag053

De Leeuw, J. C. B., Goërtz, Y. M. J., Wallin, M. K., Jaarsma, T., Friedrichsen, M., Jaarsma, P., Strömberg, A., Kurpas, D., Stefanicka-Wojtas, D., Geersing, G. J., de Graaf, E., Brunner-La Rocca, H. P., Janssen, D. J. A., Grice-Jackson, T., & RAPHAEL consortium (2026). Remote Monitoring Instruments in Palliative Care for People With Heart Failure: A Scoping Review. Journal of Pain and Symptom Management, 71(6), e696-e710. https://doi.org/10.1016/j.jpainsymman.2026.02.016

Philip, M., Dumonceau, R. G., Citro, R., Cosyns, B., Donal, E., Erba, P. A., Gouriet, F., Iung, B., Kong, W. K. F., Lancellotti, P., Maggioni, A., Mancini, J., Popescu, B. A., Prendergast, B., Sambola, A., Sengupta, S. P., Timoteo, A., Tribouilloy, C., van Melle, J. P., ... Habib, G. (2026). Clinical characteristics, management and outcomes of enterococcal infective endocarditis: an ancillary study from the ESC-EORP EURO-ENDO registry. European heart journal - Quality of care & clinical outcomes, 12(3), 308-321. https://doi.org/10.1093/ehjqcco/qcaf145

Weerts, J., Voorrips, S. N., Jeneson, J. A. L., Barandiaran Aizpurua, A., Mevenkamp, J., Sibeijn-Kuiper, A. J., Renken, R. J., Schroen, B. L. M., Knackstedt, C., Houben, A. J. H. M., van der Meer, P., Schrauwen-Hinderling, V. B., Westenbrink, B. D., & van Empel, V. P. M. (2026). Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo <SUP>31</SUP>P magnetic resonance spectroscopy. Esc heart failure, 13(2), Article xvaf035. https://doi.org/10.1093/eschf/xvaf035

de Jong, M. B. L., Allach, Y., Kamar, S. A., Clephas, P. R. D., Brunner-La Rocca, H. P., Handoko, M. L., van de Halm, V. P., Kok, W. E. M., Asselbergs, F. W., van Kimmenade, R., Beeres, S. L. M. A., Rienstra, M., Szymanski, M. K., de Boer, R. A., Kardys, I., & Brugts, J. J. (2026). The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring. Journal of Cardiac Failure, 32(4), 718-728. https://doi.org/10.1016/j.cardfail.2025.04.014

Cami, E., Verghote, E., Pecetto, E., Gonzalez, A., Brakenhielm, E., Jones, E. A., & Van Empel, V. (2026). Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets. Current Heart Failure Reports, 23(1). Advance online publication. https://doi.org/10.1007/s11897-026-00745-0

Baugh, C. W., Gibson, C. M., Giannitsis, E., Morrow, D. A., Januzzi, J. L., Papendick, C., Brunner-La Rocca, H. P., Daniels, L. B., Palau, H., Visciola, L., & Than, M. (2026). Considerations for the Adoption of Digital Algorithms and Cardiovascular Decision-Support Tools in Clinical Practice. Critical Pathways in Cardiology, 25(1), e0412. https://doi.org/10.1097/HPC.0000000000000412

Schoonvelde, S. A. C., Zwetsloot, P.-P., Hirsch, A., Schinkel, A. F. L., Knackstedt, C., Germans, T., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., & Michels, M. (2026). Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy. Heart, 112(6), 333-340. Article 326217. https://doi.org/10.1136/heartjnl-2025-326217

Vajargah, K. K., Dib, M.-J., Tavolinejad, H., Zamani, P., Richards, A. M., Mann, D. L., Rietzschel, E., van Empel, V., Burgess, S., Cappola, T. P., & Chirinos, J. A. (2026). Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure, 14(3), Article 102771. https://doi.org/10.1016/j.jchf.2025.102771

Ravassa, S., Girerd, N., Edelman, F., Lopez, B., Ferreira, J. P., Zurkan, D., Jose, G. S., Latasa, I., Pellicori, P., Cosmi, F., Petutschnigg, J., Heymans, S., Brunner-La Rocca, H.-P., Pieske, B., Delles, C., Clark, A. L., Diez, J., Zannad, F., Cleland, J. G. F., ... HOMAGE Trial Committees and Investigators (2026). Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. MedComm, 7(3), Article e70634. https://doi.org/10.1002/mco2.70634

Setjiadi, D., Delles, C., Kroon, A. A., Ressink, K., Bekers, O., Meex, S. J. R., Köhler, S., Kooman, J. P., Jansen, J. F. A., Brunner-La Rocca, H.-P., Wesselius, A., Houben, A. J. H. M., & van Greevenbroek, M. M. J. (2026). Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study. Journal of Hypertension, 44, 1329-1336. https://doi.org/10.1097/HJH.0000000000004265

Vidula, M. K., Schurgers, L. J., Zhao, L., Dib, M.-J., Zhao, M., Wang, Z., Ebert, C., Salman, O., Azzo, J. D., Zamani, P., van Empel, V., Richards, A. M., Doughty, R., Javaheri, A., Mann, D. L., Rietzschell, E., Kammerhoff, K., Schafer, P., Seiffert, D. A., ... Chirinos, J. A. (2026). Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure. Circulation-Heart Failure, 19(2), 1-11. Article e012734. https://doi.org/10.1161/CIRCHEARTFAILURE.124.012734

Keijsers, L. C. E. M., Peters, L. H. L., van Schayck, O. C. P., Muris, J. W. M., Boudewijns, E. A., Claessens, D., Willemsen, R. T. A., Salome, P. L., Boyne, J. J. J., Brunner-La Rocca, H.-P., van Pol, P. E. J., Jaarsma, T., Chavannes, N. H., Bonten, T. N., & Gidding-Slok, A. H. M. (2026). Development and psychometric properties of the 'Assessment of Burden of Chronic Conditions (ABCC) tool' for people with chronic heart failure (CHF): a mixed methods approach. Family Medicine and Community Health, 14(1), Article e003781. https://doi.org/10.1136/fmch-2025-003781

Raafs, A. G., Verdonschot, J. A. J., Knackstedt, C., Nijveldt, R., & Heymans, S. R. B. (2026). Clinical and prognostic impact of left atrial strain in non-ischemic cardiomyopathies. International Journal of Cardiovascular Imaging, 42(2), 175-193. https://doi.org/10.1007/s10554-025-03597-2

Lewis, G. D., Garcia-Pavia, P., Masri, A., Merkely, B., Nassif, M. E., Peña-Peña, M. L., Barriales-Villa, R., Bilen, O., Burroughs, M., Claggett, B., Costabel, J. P., de Barros Correia, E., Dybro, A. M., Kulac, I. J., Lakdawala, N. K., Mann, A., Maron, M. S., McGinnis, S., Nair, A., ... MAPLE-HCM Investigators (2026). Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy The MAPLE-HCM Randomized Clinical Trial. JAMA Cardiology. Advance online publication. https://doi.org/10.1001/jamacardio.2026.1730

Venner, M. F. G. H. M., Verdonschot, J. A. J., & Knackstedt, C. (2026). Letter to the editor: Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 442, Article 133886. https://doi.org/10.1016/j.ijcard.2025.133886

Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429

Gilani, K., Wei, W., Peters, C., Verket, M., Brunner-La Rocca, H.-P., Nicolis, E., Colombo, M., Marx-Schutt, K., Urovi, V., & Dumontier, M. (2026). CMEO: a metadata-centric ontology for clinical studies exploration and harmonization assessment. BMC Medical Informatics and Decision Making, 26(1), Article 8. https://doi.org/10.1186/s12911-025-03272-5

Herrmann, J. J., Van Berlo, R., Brunner-La Rocca, H.-P., Sanders-Van Wijk, S., Gommans, D. H. F., & Van Kimmenade, R. R. J. (2026). Fluid restriction in patients with heart failure: a systematic review. Heart. Advance online publication. https://doi.org/10.1136/heartjnl-2025-326784

van de Bovenkamp, A. A., Nassiri, S., de Man, F. S., Oosterveer, F. P. T., Mourmans, S. G. J., van Raalte, D. H., Dijkmans, P. A., van Heerebeek, L., van Empel, V. P. M., Eringa, E. C., Bakermans, A. J., & Handoko, M. L. (2026). Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomized clinical trial. European journal of heart failure. Advance online publication. https://doi.org/10.1093/ejhf/xuag162

Steiner, B., Neumann, A., Schwertfeger, M., Verket, M., Romero, I., Hurtado, C., Schiefel, V., McNulty, A., Sankarpandi, S., Gingele, A. J., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Patient-reported outcome and experience measures in cardiovascular disease: a scoping review as part of iCARE4CVD. Journal of patient-reported outcomes, 9(1), Article 141. https://doi.org/10.1186/s41687-025-00980-4

Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure, 27(12), 2897-2902. https://doi.org/10.1002/ejhf.3651

Gingele, A. J., Eurlings, C., Boyne, J. J., & Brunner-La Rocca, H.-P. (2025). Identifying patients' signs and symptoms to guide eHealth-directed diuretic therapy intensification in heart failure-Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Wiener Klinische Wochenschrift, 137(23-24), 774-777. https://doi.org/10.1007/s00508-025-02551-5

Malgie, J., Wilde, M. I., Koudstaal, S., Denham, R., da Fonseca, C. A., Swart, H. P., van Ofwegen, C. E. E., Yilmaz, A., Pisters, R., Linssen, G. C. M., Faber, N., van Heerebeek, L., van de Swaluw, J. E. C., de Boer, R. A., Brunner-La Rocca, H.-P., & Brugts, J. J. (2025). Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF. European journal of heart failure, 27(12), 2735-2746. https://doi.org/10.1002/ejhf.70006

Li, X., Achten, A., Nassiri, S., Mourmans, S., van de Bovenkamp, A. A., Knackstedt, C., Handoko, M. L., Weerts, J., & van Empel, V. (2025). Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohorts. Netherlands Heart Journal, 33(12), 412-420. https://doi.org/10.1007/s12471-025-02000-y

Achten, A., Peeters, L., Verkoulen, G., Weerts, J., Knackstedt, C., Boerma, E.-J., van Empel, V., & Wijk, S. S. (2025). Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity. Heart Failure Reviews, 30(6), 1207-1213. https://doi.org/10.1007/s10741-025-10540-z

Stroeks, S. L. V. M., Merlo, M., Mora-Ayestaran, N., Jason, M., Tayal, U., Wang, P., Cannatà, A., Sikking, M. A., Dal Ferro, M., Peiro, B., Willemars, M., Hellebrekers, D. M. E. I., van Leeuwen, R. E. W., Setti, M., Gonzalez-Lopez, E., Krapels, I. P. C., Pio Loco Detto Gava, C., van den Wijngaard, A., Henkens, M. T. H. M., ... Verdonschot, J. A. J. (2025). Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy. Circulation-Heart Failure, 18(11), e012592. Article 012592. https://doi.org/10.1161/CIRCHEARTFAILURE.124.012592

Tingen, H. S. A., Berends, M., Tubben, A., van der Meer, P., Slart, R. H. J. A., Bijzet, J., van der Zwaag, P. A., Kimmich, C., Knackstedt, C., Muntinghe, F. L. H., Houwerzijl, E. J., Hazenberg, B. P. C., & Nienhuis, H. L. A. (2025). Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 5000-5005. https://doi.org/10.1007/s00259-025-07328-6

Chua, A. P. A., Weerts, J., Achten, A., Nabeta, T., Sarrazyn, C., Lopez-Santi, P., Mourmans, S. G. J., Su, J. L., Bax, J. J., Knackstedt, C., van Empel, V. P. M., & Ajmone-Marsan, N. (2025). Left Atrial Strain Index in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American Society of Echocardiography, 38(11), 1099-1101. https://doi.org/10.1016/j.echo.2025.07.008

Adamo, M., Pagnesi, M., Chioncel, O., Bayes-Genis, A., Abdelhamid, M., Antohi, E.-L., Bucciarelli-Ducci, C., Chieffo, A., Cosyns, B., Gilard, M., Grapsa, J., Gonzalez, A., Gustafsson, F., Iung, B., Joner, M., Karam, N., Lund, L. H., Maisano, F., Moura, B., ... Metra, M. (2025). Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European journal of heart failure, 27(11), 2623-2633. https://doi.org/10.1002/ejhf.70023

Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P. P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J., & Michels, M. (2025). Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression. International Journal of Cardiology, 437, Article 133444. https://doi.org/10.1016/j.ijcard.2025.133444

Gawalko, M., Habibi, Z., Verhaert, D. V. M., Engels, M., Weerts, J., Adriaans, B., Chaldoupi, S.-M., ter Bekke, R. M. A., Den Uijl, D. W., Luermans, J. G. L. M., Van Empel, V. P. M., Schotten, U., Vernooy, K., & Linz, D. (2025). Discordance between left atrial pressure and risk scores in assessment of heart failure with preserved ejection fraction in patients with atrial fibrillation undergoing catheter ablation. EP Europace, 27(10), Article euaf245. https://doi.org/10.1093/europace/euaf245

Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5

D'Italia, G., Coenen, D. M., Lemmens, T. P., Brandts, L., Wielders, S. J. H., Nagy, M., Mourmans, S. G. J., Achten, A., Al-Abadi, A., Weerts, J., Aizpurua, A. B., van Empel, V., Schroen, B., & Cosemans, J. M. E. M. (2025). Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction. Esc heart failure, 12(5), 3444-3460. https://doi.org/10.1002/ehf2.15361

van Koll, J., Engels, M. D. E. A., Rijks, J. H. J., Salari, M., Luijten, J., Lumens, J., van Empel, V. P. M., Westra, S. W., van Stipdonk, A. M. W., Lankveld, T. A. R., Chaldoupi, S. M., Joza, J., Beukema, R. J., Luermans, J. G. L. M., Linz, D. K., & Vernooy, K. (2025). Long-term outcomes of pace-and-ablate strategy in patients with atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 68(7), 1487-1495. Article 100786. https://doi.org/10.1007/s10840-025-02038-3

Gilani, K., Verket, M., Peters, C., Dumontier, M., Rocca, H. P. B. L., & Urovi, V. (2025). CDE-Mapper: Using retrieval-augmented language models for linking clinical data elements to controlled vocabularies. Computers in Biology and Medicine, 196, Article 110745. https://doi.org/10.1016/j.compbiomed.2025.110745

Slob, B. P. H., Postma, M. J., Weersma, M., Rocca, H.-P. B.-L., de Jong, L. A., & Boersma, C. (2025). Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands. American journal of cardiovascular drugs : drugs, devices, and other interventions, 25(5), 715-726. https://doi.org/10.1007/s40256-025-00749-6

Geraeds, C. B. G., Bruninx, A., Dekker, A. L. A. J., Barandiaran Aizpurua, A., Bermejo, I., & Brunner-La Rocca, H.-P. (2025). Exploring safety of down-titrating diuretics in heart failure management. European journal of heart failure, 27(8), 1393-1399. https://doi.org/10.1002/ejhf.3714

Weerts, J., Schroen, B. L. M., Barandiaran Aizpurua, A., Berendschot, T. T. J. M., Brandts, L., Webers, C. A. B., Simons, S. O., Meex, S. J. R., Henry, R., van der Kallen, C. J. H., Brunner-La Rocca, H.-P., Knackstedt, C., Heymans, S. R. B., de Boer, R. A., van Empel, V. P. M., & Houben, A. J. H. M. (2025). Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study. Cardiovascular Diabetology, 24(1), Article 310. https://doi.org/10.1186/s12933-025-02850-1

Venner, M. F. G. H. M., Gevers, T. J. G., Ploum, F., Habets, J., Raafs, A. G., Weerts, J., Heymans, S. R. B., van der Leij, C., de Haan, M. W., Verdonschot, J. A. J., Kramer, M., & Knackstedt, C. (2025). Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 431, Article 133226. https://doi.org/10.1016/j.ijcard.2025.133226

Steiner, B., Verket, M., Baldewijns, K., Murphy, M., McNulty, A., Schwertfeger, M., Friedl, S., Barrett, M., Hill, L., Brandts, J., Romero, I., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Participative research for individualised care in cardiovascular diseases (PRIC-CVD): study protocol for a non-interventional, multicentre mixed-methods study as part of iCARE4CVD. BMJ Open, 15(7), Article e098061. https://doi.org/10.1136/bmjopen-2024-098061

Malgie, J., Wilde, M. I., Brunner-La Rocca, H.-P., Emans, M. E., De Boer, G. A., Siegers, C. E. P., van Stipdonk, A. M. W., Wardeh, A. J., Schaap, J., Sanders-van Wijk, S., van den Heuvel, M., Wierda, E., De Boer, R. A., Koudstaal, S., & Brugts, J. J. (2025). Newly diagnosed heart failure with reduced ejection fraction: timing, sequencing, and titration of guideline-recommended medical therapy. European Heart Journal, 46(25), 2394-2405. https://doi.org/10.1093/eurheartj/ehaf244

Gingele, A. J., Steiner, B., Zippel-Schultz, B., & Brunner-La Rocca, H.-P. (2025). Adherence to eHealth Interventions Among Patients With Heart Failure: Scoping Review. JMIR mHealth and uHealth, 13, Article e63409. https://doi.org/10.2196/63409